$163 Billion Pharmaceutical Giant Pfizer to Pay $200 Million to $250 Million to Settle 10,000 Lawsuits for Concealing Cancer Risks for Heartburn Drug Zantac Sold Between 1998 to 2006 & Discontinued in 2020 Due to Potential Link to Carcinogen N-nitrosodimethylamine, GSK Previously Reached Out-of-Court Settlement for Zantac Cancer Lawsuits, Sanofi Paid $100 Million for 4,000 Cases
16th May 2024 | Hong Kong
Pharmaceutical giant Pfizer with $163 billion market capitalization (15/5/24) has been reported to agree to pay $200 million to $250 million to settle more than 10,000 lawsuits for concealing cancer risks for heartburn drug Zantac sold between 1998 to 2006 and discontinued in 2020 due to potential link to carcinogen N-nitrosodimethylamine. Pharmaceutical giant GSK had previously reached out-of-court settlement for Zantac cancer lawsuits, and Sanofi paid $100 million for around 4,000 cases.
“ $163 Billion Pharmaceutical Giant Pfizer to Pay $200 Million to $250 Million to Settle 10,000 Lawsuits for Concealing Cancer Risks for Heartburn Drug Zantac Sold Between 1998 to 2006 & Discontinued in 2020 Due to Potential Link to Carcinogen N-nitrosodimethylamine, GSK Previously Reached Out-of-Court Settlement for Zantac Cancer Lawsuits, Sanofi Paid $100 Million for 4,000 Cases “
$163 Billion Pharmaceutical Giant Pfizer to Pay $200 Million to $250 Million to Settle 10,000 Lawsuits for Concealing Cancer Risks for Heartburn Drug Zantac Sold Between 1998 to 2006 & Discontinued in 2020 Due to Potential Link to Carcinogen N-nitrosodimethylamine, GSK Previously Reached Out-of-Court Settlement for Zantac Cancer Lawsuits, Sanofi Paid $100 Million for 4,000 Cases
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit